These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 30584960)

  • 1. Clot waveform analysis in Clauss fibrinogen assay contributes to classification of fibrinogen disorders.
    Suzuki A; Suzuki N; Kanematsu T; Shinohara S; Arai N; Kikuchi R; Matsushita T
    Thromb Res; 2019 Feb; 174():98-103. PubMed ID: 30584960
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Screening method for congenital dysfibrinogenemia using clot waveform analysis with the Clauss method.
    Arai S; Kamijo T; Hayashi F; Shinohara S; Arai N; Sugano M; Uehara T; Honda T; Okumura N
    Int J Lab Hematol; 2021 Apr; 43(2):281-289. PubMed ID: 33030793
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Automated screening procedure for the phenotypes of congenital fibrinogen disorders using novel parameters, |min1|c and Ac/|min1|c, obtained from clot waveform analysis using the Clauss method.
    Arai S; Kamijo T; Kaido T; Yoda M; Shinohara S; Suzuki T; Arai N; Sugano M; Uehara T; Okumura N
    Clin Chim Acta; 2021 Oct; 521():170-176. PubMed ID: 34273336
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development and validation of a novel qualitative test for plasma fibrinogen utilizing clot waveform analysis.
    Suzuki A; Suzuki N; Kanematsu T; Shinohara S; Kurono H; Arai N; Okamoto S; Suzuki N; Tamura S; Kikuchi R; Katsumi A; Kojima T; Matsushita T
    Sci Rep; 2022 Jan; 12(1):434. PubMed ID: 35064141
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Use of Fibrinogen Determination Methods in Differential Diagnosis of Hypofibrinogenemia and Dysfibrinogenemia.
    Skornova I; Simurda T; Stasko J; Horvath D; Zolkova J; Holly P; Brunclikova M; Samos M; Bolek T; Schnierer M; Slavik L; Kubisz P
    Clin Lab; 2021 Apr; 67(4):. PubMed ID: 33865248
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combined use of Clauss and prothrombin time-derived methods for determining fibrinogen concentrations: Screening for congenital dysfibrinogenemia.
    Xiang L; Luo M; Yan J; Liao L; Zhou W; Deng X; Deng D; Cheng P; Lin F
    J Clin Lab Anal; 2018 May; 32(4):e22322. PubMed ID: 28922493
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of the fibrinogen Clauss assay and the fibrinogen PT derived method in patients with dysfibrinogenemia.
    Miesbach W; Schenk J; Alesci S; Lindhoff-Last E
    Thromb Res; 2010 Dec; 126(6):e428-33. PubMed ID: 20947138
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Congenital structural and functional fibrinogen disorders: a primer for internists.
    Undas A; Casini A
    Pol Arch Intern Med; 2019 Dec; 129(12):913-920. PubMed ID: 31797863
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fibrinogen Clauss and prothrombin time derived method ratio can differentiate dysfibrinogenemia from hypofibrinogenemia and hyperfibrinogenemia.
    Luo M; Xiang L; Yan J; Liao L; Wu Y; Deng X; Deng D; Cheng P; Lin F
    Thromb Res; 2020 Oct; 194():197-199. PubMed ID: 32788118
    [No Abstract]   [Full Text] [Related]  

  • 10. The amplitude of coagulation curves from thrombin time tests allows dysfibrinogenemia caused by the common mutation FGG-Arg301 to be distinguished from hypofibrinogenemia.
    Jacquemin M; Vanlinthout I; Van Horenbeeck I; Debasse M; Toelen J; Schoeters J; Lavend'homme R; Freson K; Peerlinck K
    Int J Lab Hematol; 2017 Jun; 39(3):301-307. PubMed ID: 28318107
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Congenital fibrinogen disorders with repeated thrombosis.
    Zhang X; Zhang C; Wang B; Chen N; Sun G; Guo X
    J Thromb Thrombolysis; 2020 Feb; 49(2):312-315. PubMed ID: 31542854
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A correlation of thrombin generation assay and clot waveform analysis in patients on warfarin.
    Cheong MA; Tan CW; Wong WH; Kong MC; See E; Yeang SH; Koh SK; Shim YT; Lee LH; Ng HJ
    Hematology; 2022 Dec; 27(1):337-342. PubMed ID: 35255239
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Novel heterozygous dysfibrinogenemia, Sumida (AαC472S), showed markedly impaired lateral aggregation of protofibrils and mildly lower functional fibrinogen levels.
    Ikeda M; Arai S; Mukai S; Takezawa Y; Terasawa F; Okumura N
    Thromb Res; 2015 Apr; 135(4):710-7. PubMed ID: 25613923
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rotational thromboelastography for monitoring of fibrinogen concentrate therapy in fibrinogen deficiency.
    Kalina U; Stöhr HA; Bickhard H; Knaub S; Siboni SM; Mannucci PM; Peyvandi F
    Blood Coagul Fibrinolysis; 2008 Dec; 19(8):777-83. PubMed ID: 19002044
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genetics, diagnosis and clinical features of congenital hypodysfibrinogenemia: a systematic literature review and report of a novel mutation.
    Casini A; Brungs T; Lavenu-Bombled C; Vilar R; Neerman-Arbez M; de Moerloose P
    J Thromb Haemost; 2017 May; 15(5):876-888. PubMed ID: 28211264
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Congenital fibrinogen disorders: an update.
    de Moerloose P; Casini A; Neerman-Arbez M
    Semin Thromb Hemost; 2013 Sep; 39(6):585-95. PubMed ID: 23852822
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diagnosis of congenital fibrinogen disorders.
    Lebreton A; Casini A
    Ann Biol Clin (Paris); 2016 Aug; 74(4):405-12. PubMed ID: 27492693
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacokinetics, surrogate efficacy and safety evaluations of a new human plasma-derived fibrinogen concentrate (FIB Grifols) in adult patients with congenital afibrinogenemia.
    Ross CR; Subramanian S; Navarro-Puerto J; Subramanian K; Kalappanavar NK; Khayat CD; Acharya SS; Peyvandi F; Rucker K; Liang W; Vilardell D; Trimm S; Ayguasanosa J
    Thromb Res; 2021 Mar; 199():110-118. PubMed ID: 33486319
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fibrinogen.
    Stang LJ; Mitchell LG
    Methods Mol Biol; 2013; 992():181-92. PubMed ID: 23546714
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Laboratory and Genetic Investigation of Mutations Accounting for Congenital Fibrinogen Disorders.
    Neerman-Arbez M; de Moerloose P; Casini A
    Semin Thromb Hemost; 2016 Jun; 42(4):356-65. PubMed ID: 27019463
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.